• Berliba, E., Bogus, M., Vanhoutte, F., Berghmans, P.J., Good, S.S., Moussa, A., Pietropaolo, K., Murphy, R.L., Zhou, X.J. & Sommadossi, J.P., 2019. Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosis. Antimicrob Agents Chemother 63, e01201-e01219.

  • Good, S.S., Moussa, A., Zhou, X.J., Pietropaolo, K. & Sommadossi, J.P., 2020. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus. PLoS One 15, e0227104.

  • Good, S.S., Westover, J., Jung, K.H., Zhou, X.J., Moussa, A., La Colla, P., Collu, G., Canard, B. & Sommadossi, J.P., 2021. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19. Antimicrob Agents Chemother 65.

  • Hakim, M.S., Wang, W., Bramer, W.M., Geng, J., Huang, F., de Man, R.A., Peppelenbosch, M.P. & Pan, Q., 2017. The global burden of hepatitis E outbreaks: a systematic review. Liver Int 37, 19-31.

  • Kamar, N., Selves, J., Mansuy, J.M., Ouezzani, L., Peron, J.M., Guitard, J., Cointault, O., Esposito, L., Abravanel, F., Danjoux, M., Durand, D., Vinel, J.P., Izopet, J. & Rostaing, L., 2008. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358, 811-817.

  • Li, P., Li, Y., Wang, Y., Liu, J., Lavrijsen, M., Li, Y., Zhang, R., Verstegen, M.M.A., Wang, Y., Li, T.C., Ma, Z., Kainov, D.E., Bruno, M.J., de Man, R.A., van der Laan, L.J.W., Peppelenbosch, M.P. & Pan, Q., 2022. Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids. Sci Adv 8, eabj5908.

  • Li, P., Liu, J., Li, Y., Su, J., Ma, Z., Bramer, W.M., Cao, W., de Man, R.A., Peppelenbosch, M.P. & Pan, Q., 2020. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. Liver Int 40, 1516-1528.

  • Liu, K., Wang, Y., Li, J., Zhou, J., da Silva, A.M.G., Suner, C., Dai, Z., Schraauwen, R., Boor, P.P.C., Ober-Vliegen, K., van den Hil, F., Offermans, D.M., Tsikari, T., Ayada, I., Peppelenbosch, M.P., van Royen, M.E., Verstegen, M.M.A., Wang, Y., Orkin, C.M., Janssen, H.L.A., Orlova, V.V., Li, P., Mitja, O., Duarte-Neto, A.N., van der Laan, L.J.W. & Pan, Q., 2025. Macrophage-augmented organoids recapitulate the complex pathophysiology of viral diseases and enable development of multitarget therapeutics. Nat Biomed Eng 9, 1848-1868.

  • Ma, Z., de Man, R.A., Kamar, N. & Pan, Q., 2022. Chronic hepatitis E: Advancing research and patient care. J Hepatol 77, 1109-1123.

  • Pan, Q., Li, P., Liu, K., 2024. PubChem Patent Summary for WO-2025014360-A1, Guanosine nucleotide analogs for use in preventing and/or treating hepatitis e virus infection. https://pubchem.ncbi.nlm.nih.gov/patent/WO-2025014360-A1.

  • Roberts, S.S., Miller, R.K., Jones, J.K., Lindsay, K.L., Greene, M.F., Maddrey, W.C., Williams, I.T., Liu, J. & Spiegel, R.J., 2010. The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol 88, 551-559.

  • Shannon, A. & Canard, B., 2023. Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2. Antiviral Res 210, 105501.

  • Shannon, A., Fattorini, V., Sama, B., Selisko, B., Feracci, M., Falcou, C., Gauffre, P., El Kazzi, P., Delpal, A., Decroly, E., Alvarez, K., Eydoux, C., Guillemot, J.C., Moussa, A., Good, S.S., La Colla, P., Lin, K., Sommadossi, J.P., Zhu, Y., Yan, X., Shi, H., Ferron, F. & Canard, B., 2022. A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase. Nat Commun 13, 621.

  • Shukla, P., Nguyen, H.T., Faulk, K., Mather, K., Torian, U., Engle, R.E. & Emerson, S.U., 2012. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol 86, 5697-5707.

  • Todt, D., Gisa, A., Radonic, A., Nitsche, A., Behrendt, P., Suneetha, P.V., Pischke, S., Bremer, B., Brown, R.J., Manns, M.P., Cornberg, M., Bock, C.T., Steinmann, E. & Wedemeyer, H., 2016. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut 65, 1733-1743.